Segall Bryant & Hamill’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,159
Closed -$4.24M 662
2026
Q1
$4.24M Buy
19,159
+940
+5% +$230K 0.06% 325
2025
Q4
$4.62M Sell
18,219
-27,465
-60% -$6.9M 0.06% 326
2025
Q3
$11.3M Sell
45,684
-2,356
-5% -$564K 0.15% 213
2025
Q2
$11.5M Buy
48,040
+3,352
+8% +$780K 0.16% 203
2025
Q1
$10.1M Sell
44,688
-7,139
-14% -$1.57M 0.16% 213
2024
Q4
$10.7M Sell
51,827
-51,720
-50% -$11.3M 0.15% 214
2024
Q3
$25.1M Buy
103,547
+5,506
+6% +$1.29M 0.34% 93
2024
Q2
$21.5M Buy
98,041
+5,896
+6% +$1.28M 0.38% 85
2024
Q1
$20.7M Buy
92,145
+11,378
+14% +$2.57M 0.39% 90
2023
Q4
$17.8M Sell
80,767
-50,932
-39% -$10.8M 0.34% 99
2023
Q3
$28.9M Sell
131,699
-12,599
-9% -$2.85M 0.33% 89
2023
Q2
$32.5M Buy
144,298
+25,379
+21% +$5.08M 0.34% 86
2023
Q1
$22.7M Buy
118,919
+114,095
+2,365% +$22.1M 0.25% 122
2022
Q4
$890K Sell
4,824
-890
-16% -$156K 0.01% 501
2022
Q3
$950K Buy
5,714
+464
+9% +$94.4K 0.01% 498
2022
Q2
$1.08M Buy
5,250
+323
+7% +$72.8K 0.01% 484
2022
Q1
$1.19M Buy
4,927
+220
+5% +$51K 0.01% 492
2021
Q4
$1.15M Buy
4,707
+270
+6% +$61.7K 0.01% 447
2021
Q3
$906K Buy
4,437
+300
+7% +$64.2K 0.01% 544
2021
Q2
$854K Hold
4,137
0.01% 537
2021
Q1
$788K Hold
4,137
0.01% 583
2020
Q4
$784K Sell
4,137
-700
-14% -$131K 0.01% 503
2020
Q3
$852K Buy
4,837
+37
+0.8% +$5.92K 0.01% 476
2020
Q2
$737K Hold
4,800
0.01% 504
2020
Q1
$672K Hold
4,800
0.01% 524
2019
Q4
$731K Sell
4,800
-500
-9% -$73.3K 0.01% 590
2019
Q3
$765K Hold
5,300
0.01% 568
2019
Q2
$790K Hold
5,300
0.01% 578
2019
Q1
$679K Hold
5,300
0.01% 611
2018
Q4
$566K Hold
5,300
0.01% 625
2018
Q3
$606K Hold
5,300
0.01% 637
2018
Q2
$557K Buy
+5,300
New +$533K 0.01% 651

Other funds holding STE

Segall Bryant & Hamill's STE Position: Q2 2026 in Review

Segall Bryant & Hamill sold out of Steris (STE) in Q2 2026, closing a stake of 19,159 shares — an estimated $4.24M sold.

Segall Bryant & Hamill first reported a position in STE in Q2 2018 and held it in 32 quarters. The position peaked at $32.5M in Q2 2023. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Segall Bryant & Hamill reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 19,159 Steris shares in Q2 2026, an estimated $4.24M.
  • Segall Bryant & Hamill first reported a position in Steris in Q2 2018 and held it in 32 quarters.
  • Segall Bryant & Hamill's Steris position peaked at $32.5M in Q2 2023.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.